Takeda Pharmaceutical Company Limited Reclassification Adjustments On Exchange Differences On Translation Before Tax
Takeda Pharmaceutical Company Limited (TAK) reported Reclassification Adjustments On Exchange Differences On Translation Before Tax of JPY 0 for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationBeforeTax · last filed 2025-06-25
| Period end | Reclassification Adjustments On Exchange Differences On Translation Before Tax 12 month |
|---|---|
| 2025-03-31 | 0.00 JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 0.00 JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 0.00 JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 0.00 JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 112.00M JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -399.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 3.13B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -39.96B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -22.00M JPY 20-F · filed 2019-06-27 |